Co-selected mutations in VCP: a novel mechanism of resistance to VCP inhibitors

Ítems similars

• Heterozygous mutations in valosin-containing protein (VCP) and resistance to VCP inhibitors
  per: Bastola, Prabhakar, et al.
  Publicat: (2019)
• Specific mutations in the D1–D2 linker region of VCP/p97 enhance ATPase activity and confer resistance to VCP inhibitors
  per: Bastola, Prabhakar, et al.
  Publicat: (2017)
• VCP inhibitors induce endoplasmic reticulum stress, cause cell cycle arrest, trigger caspase‐mediated cell death and synergistically kill ovarian cancer cells in combination with Salubrinal
  per: Bastola, Prabhakar, et al.
  Publicat: (2016)
• Novel Nonnucleoside Inhibitors That Select Nucleoside Inhibitor Resistance Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase
  per: Zhang, Zhijun, et al.
  Publicat: (2006)
• A Neurobiological Hypothesis of Treatment-Resistant Depression – Mechanisms for Selective Serotonin Reuptake Inhibitor Non-Efficacy
  per: Coplan, Jeremy D., et al.
  Publicat: (2014)